ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global TIGIT Therapies Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-21V13005
Home | Market Reports | Health| Pharmacy
Global TIGIT Therapies Market Research Report 2023
BUY CHAPTERS

Global TIGIT Therapies Market Research Report 2025

Code: QYRE-Auto-21V13005
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Merck
Astrazeneca plc
Arcus
Astellas
BeiGene Ltd
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen

TIGIT Therapies Market

The global market for TIGIT Therapies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for TIGIT Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for TIGIT Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for TIGIT Therapies in Cell Carcinoma is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of TIGIT Therapies include Roche, Merck, AstraZeneca, Arcus, Astellas, BeiGene, BMS, Junshi Biosciences, Innovent Biologics, Mereo BioPharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for TIGIT Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TIGIT Therapies.
The TIGIT Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global TIGIT Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TIGIT Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of TIGIT Therapies Market Report

Report Metric Details
Report Name TIGIT Therapies Market
Segment by Type
  • Monotherapy
  • Combination Therapy
Segment by Application
  • Cell Carcinoma
  • Solid Tumor
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Merck, AstraZeneca, Arcus, Astellas, BeiGene, BMS, Junshi Biosciences, Innovent Biologics, Mereo BioPharma, Seattle Genetics, Hengrui Medicine, Compugen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of TIGIT Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the TIGIT Therapies Market report?

Ans: The main players in the TIGIT Therapies Market are Roche, Merck, AstraZeneca, Arcus, Astellas, BeiGene, BMS, Junshi Biosciences, Innovent Biologics, Mereo BioPharma, Seattle Genetics, Hengrui Medicine, Compugen

What are the Application segmentation covered in the TIGIT Therapies Market report?

Ans: The Applications covered in the TIGIT Therapies Market report are Cell Carcinoma, Solid Tumor

What are the Type segmentation covered in the TIGIT Therapies Market report?

Ans: The Types covered in the TIGIT Therapies Market report are Monotherapy, Combination Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TIGIT Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global TIGIT Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cell Carcinoma
1.3.3 Solid Tumor
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global TIGIT Therapies Market Perspective (2020-2031)
2.2 Global TIGIT Therapies Growth Trends by Region
2.2.1 Global TIGIT Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 TIGIT Therapies Historic Market Size by Region (2020-2025)
2.2.3 TIGIT Therapies Forecasted Market Size by Region (2026-2031)
2.3 TIGIT Therapies Market Dynamics
2.3.1 TIGIT Therapies Industry Trends
2.3.2 TIGIT Therapies Market Drivers
2.3.3 TIGIT Therapies Market Challenges
2.3.4 TIGIT Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top TIGIT Therapies Players by Revenue
3.1.1 Global Top TIGIT Therapies Players by Revenue (2020-2025)
3.1.2 Global TIGIT Therapies Revenue Market Share by Players (2020-2025)
3.2 Global TIGIT Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by TIGIT Therapies Revenue
3.4 Global TIGIT Therapies Market Concentration Ratio
3.4.1 Global TIGIT Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TIGIT Therapies Revenue in 2024
3.5 Global Key Players of TIGIT Therapies Head office and Area Served
3.6 Global Key Players of TIGIT Therapies, Product and Application
3.7 Global Key Players of TIGIT Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 TIGIT Therapies Breakdown Data by Type
4.1 Global TIGIT Therapies Historic Market Size by Type (2020-2025)
4.2 Global TIGIT Therapies Forecasted Market Size by Type (2026-2031)
5 TIGIT Therapies Breakdown Data by Application
5.1 Global TIGIT Therapies Historic Market Size by Application (2020-2025)
5.2 Global TIGIT Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America TIGIT Therapies Market Size (2020-2031)
6.2 North America TIGIT Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America TIGIT Therapies Market Size by Country (2020-2025)
6.4 North America TIGIT Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe TIGIT Therapies Market Size (2020-2031)
7.2 Europe TIGIT Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe TIGIT Therapies Market Size by Country (2020-2025)
7.4 Europe TIGIT Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific TIGIT Therapies Market Size (2020-2031)
8.2 Asia-Pacific TIGIT Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific TIGIT Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific TIGIT Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America TIGIT Therapies Market Size (2020-2031)
9.2 Latin America TIGIT Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America TIGIT Therapies Market Size by Country (2020-2025)
9.4 Latin America TIGIT Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa TIGIT Therapies Market Size (2020-2031)
10.2 Middle East & Africa TIGIT Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa TIGIT Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa TIGIT Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche TIGIT Therapies Introduction
11.1.4 Roche Revenue in TIGIT Therapies Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck TIGIT Therapies Introduction
11.2.4 Merck Revenue in TIGIT Therapies Business (2020-2025)
11.2.5 Merck Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca TIGIT Therapies Introduction
11.3.4 AstraZeneca Revenue in TIGIT Therapies Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Arcus
11.4.1 Arcus Company Details
11.4.2 Arcus Business Overview
11.4.3 Arcus TIGIT Therapies Introduction
11.4.4 Arcus Revenue in TIGIT Therapies Business (2020-2025)
11.4.5 Arcus Recent Development
11.5 Astellas
11.5.1 Astellas Company Details
11.5.2 Astellas Business Overview
11.5.3 Astellas TIGIT Therapies Introduction
11.5.4 Astellas Revenue in TIGIT Therapies Business (2020-2025)
11.5.5 Astellas Recent Development
11.6 BeiGene
11.6.1 BeiGene Company Details
11.6.2 BeiGene Business Overview
11.6.3 BeiGene TIGIT Therapies Introduction
11.6.4 BeiGene Revenue in TIGIT Therapies Business (2020-2025)
11.6.5 BeiGene Recent Development
11.7 BMS
11.7.1 BMS Company Details
11.7.2 BMS Business Overview
11.7.3 BMS TIGIT Therapies Introduction
11.7.4 BMS Revenue in TIGIT Therapies Business (2020-2025)
11.7.5 BMS Recent Development
11.8 Junshi Biosciences
11.8.1 Junshi Biosciences Company Details
11.8.2 Junshi Biosciences Business Overview
11.8.3 Junshi Biosciences TIGIT Therapies Introduction
11.8.4 Junshi Biosciences Revenue in TIGIT Therapies Business (2020-2025)
11.8.5 Junshi Biosciences Recent Development
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Details
11.9.2 Innovent Biologics Business Overview
11.9.3 Innovent Biologics TIGIT Therapies Introduction
11.9.4 Innovent Biologics Revenue in TIGIT Therapies Business (2020-2025)
11.9.5 Innovent Biologics Recent Development
11.10 Mereo BioPharma
11.10.1 Mereo BioPharma Company Details
11.10.2 Mereo BioPharma Business Overview
11.10.3 Mereo BioPharma TIGIT Therapies Introduction
11.10.4 Mereo BioPharma Revenue in TIGIT Therapies Business (2020-2025)
11.10.5 Mereo BioPharma Recent Development
11.11 Seattle Genetics
11.11.1 Seattle Genetics Company Details
11.11.2 Seattle Genetics Business Overview
11.11.3 Seattle Genetics TIGIT Therapies Introduction
11.11.4 Seattle Genetics Revenue in TIGIT Therapies Business (2020-2025)
11.11.5 Seattle Genetics Recent Development
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Details
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine TIGIT Therapies Introduction
11.12.4 Hengrui Medicine Revenue in TIGIT Therapies Business (2020-2025)
11.12.5 Hengrui Medicine Recent Development
11.13 Compugen
11.13.1 Compugen Company Details
11.13.2 Compugen Business Overview
11.13.3 Compugen TIGIT Therapies Introduction
11.13.4 Compugen Revenue in TIGIT Therapies Business (2020-2025)
11.13.5 Compugen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche
Merck
Astrazeneca plc
Arcus
Astellas
BeiGene Ltd
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
List of Tables
 Table 1. Global TIGIT Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monotherapy
 Table 3. Key Players of Combination Therapy
 Table 4. Global TIGIT Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global TIGIT Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global TIGIT Therapies Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global TIGIT Therapies Market Share by Region (2020-2025)
 Table 8. Global TIGIT Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global TIGIT Therapies Market Share by Region (2026-2031)
 Table 10. TIGIT Therapies Market Trends
 Table 11. TIGIT Therapies Market Drivers
 Table 12. TIGIT Therapies Market Challenges
 Table 13. TIGIT Therapies Market Restraints
 Table 14. Global TIGIT Therapies Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global TIGIT Therapies Market Share by Players (2020-2025)
 Table 16. Global Top TIGIT Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TIGIT Therapies as of 2024)
 Table 17. Ranking of Global Top TIGIT Therapies Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by TIGIT Therapies Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of TIGIT Therapies, Headquarters and Area Served
 Table 20. Global Key Players of TIGIT Therapies, Product and Application
 Table 21. Global Key Players of TIGIT Therapies, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global TIGIT Therapies Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global TIGIT Therapies Revenue Market Share by Type (2020-2025)
 Table 25. Global TIGIT Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global TIGIT Therapies Revenue Market Share by Type (2026-2031)
 Table 27. Global TIGIT Therapies Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global TIGIT Therapies Revenue Market Share by Application (2020-2025)
 Table 29. Global TIGIT Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global TIGIT Therapies Revenue Market Share by Application (2026-2031)
 Table 31. North America TIGIT Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America TIGIT Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America TIGIT Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe TIGIT Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe TIGIT Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe TIGIT Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific TIGIT Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific TIGIT Therapies Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific TIGIT Therapies Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America TIGIT Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America TIGIT Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America TIGIT Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa TIGIT Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa TIGIT Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa TIGIT Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Roche Company Details
 Table 47. Roche Business Overview
 Table 48. Roche TIGIT Therapies Product
 Table 49. Roche Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 50. Roche Recent Development
 Table 51. Merck Company Details
 Table 52. Merck Business Overview
 Table 53. Merck TIGIT Therapies Product
 Table 54. Merck Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 55. Merck Recent Development
 Table 56. AstraZeneca Company Details
 Table 57. AstraZeneca Business Overview
 Table 58. AstraZeneca TIGIT Therapies Product
 Table 59. AstraZeneca Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 60. AstraZeneca Recent Development
 Table 61. Arcus Company Details
 Table 62. Arcus Business Overview
 Table 63. Arcus TIGIT Therapies Product
 Table 64. Arcus Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 65. Arcus Recent Development
 Table 66. Astellas Company Details
 Table 67. Astellas Business Overview
 Table 68. Astellas TIGIT Therapies Product
 Table 69. Astellas Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 70. Astellas Recent Development
 Table 71. BeiGene Company Details
 Table 72. BeiGene Business Overview
 Table 73. BeiGene TIGIT Therapies Product
 Table 74. BeiGene Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 75. BeiGene Recent Development
 Table 76. BMS Company Details
 Table 77. BMS Business Overview
 Table 78. BMS TIGIT Therapies Product
 Table 79. BMS Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 80. BMS Recent Development
 Table 81. Junshi Biosciences Company Details
 Table 82. Junshi Biosciences Business Overview
 Table 83. Junshi Biosciences TIGIT Therapies Product
 Table 84. Junshi Biosciences Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 85. Junshi Biosciences Recent Development
 Table 86. Innovent Biologics Company Details
 Table 87. Innovent Biologics Business Overview
 Table 88. Innovent Biologics TIGIT Therapies Product
 Table 89. Innovent Biologics Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 90. Innovent Biologics Recent Development
 Table 91. Mereo BioPharma Company Details
 Table 92. Mereo BioPharma Business Overview
 Table 93. Mereo BioPharma TIGIT Therapies Product
 Table 94. Mereo BioPharma Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 95. Mereo BioPharma Recent Development
 Table 96. Seattle Genetics Company Details
 Table 97. Seattle Genetics Business Overview
 Table 98. Seattle Genetics TIGIT Therapies Product
 Table 99. Seattle Genetics Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 100. Seattle Genetics Recent Development
 Table 101. Hengrui Medicine Company Details
 Table 102. Hengrui Medicine Business Overview
 Table 103. Hengrui Medicine TIGIT Therapies Product
 Table 104. Hengrui Medicine Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 105. Hengrui Medicine Recent Development
 Table 106. Compugen Company Details
 Table 107. Compugen Business Overview
 Table 108. Compugen TIGIT Therapies Product
 Table 109. Compugen Revenue in TIGIT Therapies Business (2020-2025) & (US$ Million)
 Table 110. Compugen Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. TIGIT Therapies Picture
 Figure 2. Global TIGIT Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global TIGIT Therapies Market Share by Type: 2024 VS 2031
 Figure 4. Monotherapy Features
 Figure 5. Combination Therapy Features
 Figure 6. Global TIGIT Therapies Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global TIGIT Therapies Market Share by Application: 2024 VS 2031
 Figure 8. Cell Carcinoma Case Studies
 Figure 9. Solid Tumor Case Studies
 Figure 10. TIGIT Therapies Report Years Considered
 Figure 11. Global TIGIT Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global TIGIT Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global TIGIT Therapies Market Share by Region: 2024 VS 2031
 Figure 14. Global TIGIT Therapies Market Share by Players in 2024
 Figure 15. Global Top TIGIT Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TIGIT Therapies as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by TIGIT Therapies Revenue in 2024
 Figure 17. North America TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America TIGIT Therapies Market Share by Country (2020-2031)
 Figure 19. United States TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe TIGIT Therapies Market Share by Country (2020-2031)
 Figure 23. Germany TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific TIGIT Therapies Market Share by Region (2020-2031)
 Figure 31. China TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America TIGIT Therapies Market Share by Country (2020-2031)
 Figure 39. Mexico TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa TIGIT Therapies Market Share by Country (2020-2031)
 Figure 43. Turkey TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE TIGIT Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Roche Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 47. Merck Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 48. AstraZeneca Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 49. Arcus Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 50. Astellas Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 51. BeiGene Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 52. BMS Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 53. Junshi Biosciences Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 54. Innovent Biologics Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 55. Mereo BioPharma Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 56. Seattle Genetics Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 57. Hengrui Medicine Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 58. Compugen Revenue Growth Rate in TIGIT Therapies Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global TCR T Therapy Market Research Report 2024
Global Regulatory T Cell Tregs Therapies Market Research Report 2024
Global Dermatitis Herpetiformis Treatment Drugs Market Research Report 2024
Global Epigenetic Therapeutics Market Research Report 2024
Global Tigecycline Injection Market Research Report 2025
Global CAR T Therapy Market Research Report 2024
Global TiC Powder Market Research Report 2025
Global Tactors Market Research Report 2024
Global T Cell Transfer Therapy Market Research Report 2024
Global Pentetrazol Market Research Report 2025
Global Radioligand Therapy Market Research Report 2025
Global Naturopathy Therapies Market Research Report 2024
Tiratricol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Novel T Cell Immunotherapies Market Research Report 2024
Global Pain Management Therapie Market Research Report 2024
Global Infusion Therapies and Technology Market Research Report 2024
Global Therapy Guns Market Research Report 2024
Global Transmucosal Drug Delivery Devices Market Research Report 2024
Global TIG Equipment Market Research Report 2024
Global Cellulitis Treatment Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions